Irving Blake 4

What Happened

• Irving Blake, a director of DocuSign (DOCU), reported two related transactions: an exercise/conversion of 729 derivative units on 2026-05-29 (reported as both acquired and disposed) and a grant of 4,384 restricted stock units (RSUs) on 2026-06-01. All transactions show a $0.00 price (no cash exchanged).

Key Details

• Transaction dates and types:
  • 2026-05-29: Exercise/conversion of derivative (M) — 729 units @ $0.00 (reported as both acquired and disposed).
  • 2026-06-01: Grant/award (A) — 4,384 RSUs @ $0.00 (acquired).
• Reported value: $0.00 per share/unit (typical for RSU awards and certain conversions).
• Shares owned after transaction: Not specified in the provided filing.
• Filing timeliness: Form 4 filed 2026-06-02 — appears timely (within required business-day window).
• Footnotes of note:
  • F1: Each RSU converts to one share upon vesting.
  • F2/F4: Vesting schedule — RSUs vest in equal quarterly installments over one year; the fourth installment may fully vest earlier (company annual meeting or one-year anniversary), subject to continued service.
  • F3: These RSUs do not expire; they either vest or are canceled prior to vesting.

Context

• The 729-unit entry is a derivative exercise/conversion (code M). The filing shows both acquisition and disposition entries for that derivative on the same date — the form records the conversion/settlement of a derivative instrument rather than an open-market sale. No immediate sale of the newly issued shares is shown.
• The 4,384 items are RSU awards (compensation/retention grants) that will vest over ~1 year if the director remains a service provider. Such grants are common corporate compensation and are informational rather than direct buy/sell signals about the insider's market view.